Company profile RBOT
There is not enough data for Vicarious Surgical healthcare to provide analysis
There is not enough data for Vicarious Surgical healthcare to provide correlation calculation
There is not enough data for Vicarious Surgical healthcare to provide analysis
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. Vicarious Surgical stock expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 28 | 59 110.7% QoQ | 92 55.9% QoQ | 41 -55.4% QoQ |
| 2020 | 58 107.1% YoY 41.5% QoQ | 31 -47.5% YoY -46.6% QoQ | 78 -15.2% YoY 151.6% QoQ | 41 0.0% YoY -47.4% QoQ |
| 2021 | 74 27.6% YoY 80.5% QoQ | 149 380.6% YoY 101.4% QoQ | 152 94.9% YoY 2.0% QoQ | 127 209.8% YoY -16.4% QoQ |
| 2022 | 63 -14.9% YoY -50.4% QoQ | 76 -49.0% YoY 20.6% QoQ | 48 -68.4% YoY -36.8% QoQ | 147 15.7% YoY 206.2% QoQ |
| 2023 | 111 76.2% YoY -24.5% QoQ | 41 -46.1% YoY -63.1% QoQ | 170 254.2% YoY 314.6% QoQ | 52 -64.6% YoY -69.4% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of Vicarious Surgical stock was 6.28 per week. The last year interest of Vicarious Surgical stock compared to the last 5 years has changed by 14.49%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 46.14%.
There is not enough data for Vicarious Surgical robot to provide analysis
There is not enough data for Vicarious Surgical robot to provide correlation calculation
There is not enough data for Vicarious Surgical robot to provide analysis
There is not enough data for Vicarious Surgical System to provide analysis
There is not enough data for Vicarious Surgical System to provide correlation calculation
There is not enough data for Vicarious Surgical System to provide analysis
There is not enough data for single-port surgical robot to provide analysis
There is not enough data for single-port surgical robot to provide correlation calculation
There is not enough data for single-port surgical robot to provide analysis
After 39 days of this quarter the interest is at 320.0. Based on that we can calculate that during remaining 52 days it will total up to 747.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 514 | 894 73.9% QoQ | 892 -0.2% QoQ | 795 -10.9% QoQ |
| 2020 | 809 57.4% YoY 1.8% QoQ | 614 -31.3% YoY -24.1% QoQ | 791 -11.3% YoY 28.8% QoQ | 752 -5.4% YoY -4.9% QoQ |
| 2021 | 753 -6.9% YoY 0.1% QoQ | 885 44.1% YoY 17.5% QoQ | 901 13.9% YoY 1.8% QoQ | 804 6.9% YoY -10.8% QoQ |
| 2022 | 852 13.1% YoY 6.0% QoQ | 777 -12.2% YoY -8.8% QoQ | 789 -12.4% YoY 1.5% QoQ | 728 -9.5% YoY -7.7% QoQ |
| 2023 | 816 -4.2% YoY 12.1% QoQ | 871 12.1% YoY 6.7% QoQ | 885 12.2% YoY 1.6% QoQ | 883 21.3% YoY -0.2% QoQ |
| 2024 | 320 -60.8% YoY -63.8% QoQ | - | - | - |
The average 5 years interest of minimally invasive surgery was 62.55 per week. The last year interest of minimally invasive surgery compared to the last 5 years has changed by 4.41%. The interest for minimally invasive surgery is relatively stable in the last 5 years. The last year interest is comparable to 5 years ago. It has changed only by -1.42%.
There is not enough data for Vicarious Surgical headquarters to provide analysis
There is not enough data for Vicarious Surgical headquarters to provide correlation calculation
There is not enough data for Vicarious Surgical headquarters to provide analysis
There is not enough data for Vicarious Surgical contact to provide analysis
There is not enough data for Vicarious Surgical contact to provide correlation calculation
There is not enough data for Vicarious Surgical contact to provide analysis
There is not enough data for Vicarious Surgical CEO to provide analysis
There is not enough data for Vicarious Surgical CEO to provide correlation calculation
There is not enough data for Vicarious Surgical CEO to provide analysis